Tenderwize
Back to tender search

Open House Discount Agreement for Sultamicillin

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Mar 31, 2027 · 222 days left·Open·Supplies
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Sultamicillin, ATC J01CR04

20/100

Opportunity Score

Needs reviewLow complexity
SuppliesOpen
Why this score?

Opportunity

20 / 100

Complexity

15 / 100

Risk factors

No contract value or volume estimates provided. The opportunity may be small if Sultamicillin is a niche product.

The buyer reserves the right to replace Open House contracts with exclusive discount agreements from EU tenders at any...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Non-exclusive discount agreements for Sultamicillin (ATC J01CR04) under German social code SGB V §§ 130a Abs. 8/130c Abs. 1.
  • Pharmaceutical companies can enroll at any time during the 24-month window (01.06.2025 – 31.05.2027), with contracts starting on the first of each month.
Show full summary

Non-exclusive discount agreement (Open House) for pharmaceutical products with active ingredient Sultamicillin (ATC J01CR04) by AOK Rheinland-Pfalz/Saarland. The contract period runs from 01.06.2025 to 31.05.2027, with continuous enrollment possible each month. This is not a public procurement contract subject to EU directives but a voluntary transparency publication. No estimated value or award criteria are specified. Submission is paper-only. The place of performance is Eisenberg, Germany. The tender is EU-funded according to structured data, but XML notice indicates no EU funds (inconsistency noted).

Risks

No contract value or volume estimates provided. The opportunity may be small if Sultamicillin is a niche product.

The buyer reserves the right to replace Open House contracts with exclusive discount agreements from EU tenders at any...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Only authorized and marketable drugs in Germany may be supplied.
  • For drugs not yet listed in Lauer-Taxe at time of application, proof of marketability via AMIce database extract or equivalent evidence is required.

Administrative

  • Submission must be in paper form (electronic submission not allowed).

Requirements may be incomplete.

Award Criteria

Lot 1

No award criteria specified; the Open House model implies all eligible participants are accepted.

Buyer

Lots (1)

LOT-0001

Open House Discount Agreement for Sultamicillin

Non-exclusive discount agreement for Sultamicillin. All interested pharmaceutical companies can join under uniform conditions. Maximum contract duration 24 months, earliest start 01.06.2025. Contract ends automatically if exclusive discount agreements are concluded via EU tender. Applications must be submitted in paper form by the end of the month prior to the desired start month.

SuppliesEU fundedElectronic submission

Location

Eisenberg, Germany

Duration

May 2025 - May 2027

Category

Pharmaceutical products

Award Criteria

No award criteria specified; the Open House model implies all eligible participants are accepted.

Deadline

Deadline Mar 31, 2027

Procurement Details

Publication date
10 Apr 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
235368-2025

Documents (1)

Similar tenders